SG146690A1 - Infusion preparation containing (2r)-2-propyloctanoic acid as the active ingredient - Google Patents

Infusion preparation containing (2r)-2-propyloctanoic acid as the active ingredient

Info

Publication number
SG146690A1
SG146690A1 SG200807295-1A SG2008072951A SG146690A1 SG 146690 A1 SG146690 A1 SG 146690A1 SG 2008072951 A SG2008072951 A SG 2008072951A SG 146690 A1 SG146690 A1 SG 146690A1
Authority
SG
Singapore
Prior art keywords
infusion preparation
propyloctanoic acid
active ingredient
preparation containing
salt
Prior art date
Application number
SG200807295-1A
Other languages
English (en)
Inventor
Masao Sudoh
Seiichi Tanikawa
Original Assignee
Ono Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ono Pharmaceutical Co filed Critical Ono Pharmaceutical Co
Publication of SG146690A1 publication Critical patent/SG146690A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
SG200807295-1A 2003-10-03 2004-10-01 Infusion preparation containing (2r)-2-propyloctanoic acid as the active ingredient SG146690A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2003345125 2003-10-03

Publications (1)

Publication Number Publication Date
SG146690A1 true SG146690A1 (en) 2008-10-30

Family

ID=34419442

Family Applications (1)

Application Number Title Priority Date Filing Date
SG200807295-1A SG146690A1 (en) 2003-10-03 2004-10-01 Infusion preparation containing (2r)-2-propyloctanoic acid as the active ingredient

Country Status (17)

Country Link
US (1) US20070066686A1 (fr)
EP (1) EP1669066A4 (fr)
JP (1) JP4715516B2 (fr)
CN (1) CN1889941A (fr)
AU (1) AU2004277828A1 (fr)
BR (1) BRPI0414968A (fr)
CA (1) CA2540671A1 (fr)
EC (1) ECSP066476A (fr)
IL (1) IL174691A0 (fr)
IS (1) IS8428A (fr)
MA (1) MA28143A1 (fr)
MX (1) MXPA06003605A (fr)
NO (1) NO20061458L (fr)
RU (1) RU2006114834A (fr)
SG (1) SG146690A1 (fr)
WO (1) WO2005032538A1 (fr)
ZA (1) ZA200602689B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7980168B2 (en) * 2007-06-26 2011-07-19 Maurer Scott D Hot beverage maker with filter deforming member
US20100130619A1 (en) * 2008-11-24 2010-05-27 Joseph Schwarz Pharmaceutical composition for parenteral administration of idebenone
RU2549448C1 (ru) * 2014-05-20 2015-04-27 Екофарм Патент Менеджмент Аг Сбалансированный инфузионный раствор
CN104931424A (zh) * 2015-05-06 2015-09-23 山东师范大学 一种改进的z扫描非线性测量的实验装置及方法
CN109593676B (zh) * 2018-12-21 2023-04-07 江苏大学 一种用于酸菜发酵液中微生物分离的培养基及其制备方法
WO2020168191A1 (fr) * 2019-02-14 2020-08-20 North Grove Investments, Inc. Compositions pour maintenir la viabilité d'un matériau biologique vivant et statique, leurs procédés de production et leurs utilisations
RU2699222C1 (ru) * 2019-04-29 2019-09-04 Алексей Владимирович Воронов Солевой электролитный раствор для проведения энтеральных инфузий

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0632008B1 (fr) * 1993-06-01 1998-02-04 Ono Pharmaceutical Co., Ltd. Dérivés de l'acide pentanoique
JPH0782146A (ja) * 1993-07-23 1995-03-28 Sagami Chem Res Center 抗痴呆薬
JPH07285911A (ja) * 1994-04-20 1995-10-31 New Japan Chem Co Ltd 脂肪族モノカルボン酸組成物
JPH0853351A (ja) * 1994-08-11 1996-02-27 Sagami Chem Res Center 酵素阻害剤、血管新生抑制剤、および癌転移抑制剤
US6043223A (en) * 1997-11-12 2000-03-28 The Regents Of The University Of California Enhanced opening of abnormal brain tissue capillaries
TWI268921B (en) * 1999-02-18 2006-12-21 Ono Pharmaceutical Co A process for preparing (2R)-2-propyloctanoic acid
CN1452629A (zh) * 2000-05-31 2003-10-29 科学技术振兴事业团 含有人参皂甙Rb1的皮肤组织再生促进剂
KR100759771B1 (ko) * 2000-07-18 2007-10-04 오노 야꾸힝 고교 가부시키가이샤 성상세포 기능 개선제를 유효 성분으로 함유하는 파킨슨병치료제
JP4706950B2 (ja) * 2000-07-18 2011-06-22 小野薬品工業株式会社 アストロサイト機能改善剤を有効成分として含有するパーキンソン病治療剤
US20040176347A1 (en) * 2001-07-18 2004-09-09 Kaneyoshi Honjo Agent for treatment of cerebral ischemic diseases

Also Published As

Publication number Publication date
US20070066686A1 (en) 2007-03-22
ZA200602689B (en) 2007-06-27
JP4715516B2 (ja) 2011-07-06
AU2004277828A1 (en) 2005-04-14
EP1669066A4 (fr) 2009-04-29
CN1889941A (zh) 2007-01-03
RU2006114834A (ru) 2007-11-20
NO20061458L (no) 2006-07-03
IS8428A (is) 2006-04-25
IL174691A0 (en) 2006-08-20
WO2005032538A1 (fr) 2005-04-14
MXPA06003605A (es) 2006-06-14
BRPI0414968A (pt) 2006-11-07
JPWO2005032538A1 (ja) 2006-12-14
CA2540671A1 (fr) 2005-04-14
EP1669066A1 (fr) 2006-06-14
MA28143A1 (fr) 2006-09-01
ECSP066476A (es) 2007-03-29

Similar Documents

Publication Publication Date Title
ECSP066477A (es) Composición farmacéutica que comprende ácido (2r)-2-propiloctanoico como un ingrediente activo
EA200400777A1 (ru) Фармацевтические композиции соединения платины
EP0391002A3 (fr) Compositions pharmaceutiques contenant de l'acide anthranilique N-(3-4-diméthoxycinnamoyl)
EA200001125A1 (ru) Гелеобразные фармацевтические композиции
IL162214A (en) Pyridine derivatives and pharmaceutical compositions containing the same
AU8057401A (en) Antimicrobial composition useful for the treatment of bovine mastitis
EP0911331A3 (fr) Dérivés substitués de dibenzoxazépine, compositions pharmaceutiques et procédés d'utilisation
ECSP066476A (es) Preparación de una infusión que comprende ácido (2r)-2-propiloctanoico como ingrediente activo
EP1666041A3 (fr) Derivés de la xanthine contre désordres neurodégénératifs
EA200501129A1 (ru) Парентеральные композиции пептида для лечения системной красной волчанки
MY136546A (en) A pharmaceutical component based on human parathyroid harmone and a pharmaceutical composition for intranasal administration comprising the component
WO2004095921A3 (fr) Composition sporicide
TR200101090T2 (tr) Sertralin ağız konsantratı
PH12014500782A1 (en) Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
HUT56488A (en) Stabilizer for compositions comprising 4-ethyl-2-hydroxyimino-5-nitro-3-hexenamide, stabilizing method and stabilized medicine
MY129892A (en) The meglumine salt of a 1,2,3,4-tetrahydro-2-quinoline carboxylic acid
EA200300900A1 (ru) Замещенные амины (варианты), способ их получения и их применение в качестве ингибиторов транспорта глицина (варианты), композиция (варианты), промежуточный иодид и способ его получения, способ лечения пациента (варианты)
EP1145716A3 (fr) Agent thérapeutique pour traitement de la dermatite
AR048821A1 (es) "preparacion de infusion que comprende acido (2r)-2-propiloctanoico como un ingrediente activo y recipiente"
BG105207A (en) Pharmaceutical composition with antitumour activity on the basis of carboplatin
RU2002121504A (ru) Лекарственные средства для лечения дегенеративного артрита
TH66266A (th) สารประกอบทางเคมี
TH76933A (th) เฟนิลอินโดลสำหรับการรักษาโรคที่เกี่ยวกับ hiv
UA80802C2 (en) Low hygroscopic aripiprazole drug substance and process for the preparation thereof
HU9603631D0 (en) Pharmaceutical compositions